Nobiletin downregulates the SKP2-p21/p27-CDK2 axis to inhibit tumor progression and shows synergistic effects with palbociclib on renal cell carcinoma

Chen, TT; Liu, L; Zou, YH; Hu, XY; Zhang, WF; Zhou, T; Luo, X; Fu, WH; Xu, J

Fu, WH; Xu, J (corresponding author), Army Med Univ, Dept Urol, Xinqiao Hosp, Chongqing 400037, Peoples R China.

CANCER BIOLOGY & MEDICINE, 2021; 18 (1): 227